Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Eur Addict Res ; 15(3): 157-62, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19420948

RESUMO

BACKGROUND: Opiate substitution therapy (OST) in the Ukraine was not provided until 2004. As part of the introduction of OST, the first feasibility study was conducted in 2007. Six clinics in 6 cities were involved in providing OST and collecting data. METHODS: A total of 151 opiate-dependent patients were given buprenorphine as a substitute, and a survey of substance use, HIV transmission risks, and legal and social status was conducted at baseline and at 6 and 12-month follow-up. RESULTS: Illegal substance use and illegal activities and incomes were highly reduced, whereas employment rates and psychiatric problems improved. Retention was comparatively high (79.5%) after 12 months. No significant adverse events were reported. CONCLUSION: A successful implementation of OST in the Ukraine is feasible.


Assuntos
Buprenorfina/administração & dosagem , Transtornos Relacionados ao Uso de Opioides/tratamento farmacológico , Transtornos Relacionados ao Uso de Opioides/epidemiologia , Adulto , Estudos de Viabilidade , Feminino , Seguimentos , Humanos , Masculino , Resultado do Tratamento , Ucrânia/epidemiologia
2.
Int J Drug Policy ; 21(3): 229-33, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-19926271

RESUMO

BACKGROUND: Opioid substitution therapy (OST) in the Ukraine was not provided until 2004. Methadone maintenance therapy only became available in May 2008. Injecting drug users in Ukraine are predominantly injecting self-made opioid solution ('Shirka'). A feasibility study on buprenorphine and methadone maintenance treatment was conducted in 2008. METHODS: A total of 331 opioid dependent patients were given buprenorphine (n=191) or methadone (n=140) as a substitute, and a survey of substance use, HIV transmission risks, and legal and social status was conducted at baseline and at six months follow-up. RESULTS: Illegal substance use, illegal activities, incomes and HIV related transmission risks were highly reduced, whereas employment rates and psychiatric problems improved. Retention was comparatively high among the patients in buprenorphine (84.8%) and in methadone maintenance treatment (85.0%) after six months of treatment. CONCLUSION: These data show the successful implementation of OST in the Ukraine among drug users who were predominantly injectors of self-made opioid solutions. Continuing scale-up of OST in the Ukraine is therefore both feasible and highly recommended.


Assuntos
Comportamento Aditivo/tratamento farmacológico , Buprenorfina/uso terapêutico , Metadona/uso terapêutico , Transtornos Relacionados ao Uso de Opioides/reabilitação , Adulto , Emprego/estatística & dados numéricos , Estudos de Viabilidade , Feminino , Infecções por HIV/complicações , Infecções por HIV/transmissão , Humanos , Masculino , Adesão à Medicação/estatística & dados numéricos , Transtornos Relacionados ao Uso de Opioides/complicações , Assunção de Riscos , Resultado do Tratamento , Ucrânia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA